开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-08-26 慢热型选手来自河北省

一审目前7个月了。。。这正常吗

31 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-06-24 123dc049m24(暂无昵称) 来自广东省

从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了

72 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2023-12-01 ms2000000658865901 来自广东省

偏重的研究方向：机制
经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-08-07 124fb7cam10暂无昵称来自山西省

请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？

51 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2022-08-19 121c6f2dm84(暂无昵称)

审稿速度:6.0
经验分享：under consideration80天了，谁说这个快来着。。

139 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2023-06-08 影像哥哥来自山东省

偏重的研究方向：非编码RNA与肿瘤
经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。

91 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-04-24 白衣13 来自伊利诺伊

求好运，编辑和审稿人一生平安！！！

Manuscript Under Consideration 11th Apr 24 05:59:46
Editor Assigned 10th Apr 24 04:50:35
Manuscript Received 10th Apr 24 04:50:34

76 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-02-19 ms5000001629270806 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂

103 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-06-24 123dc049m24(暂无昵称) 来自广东省

从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了

72 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222482, encodeId=53bc222248298, content=一审目前7个月了。。。这正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58d55497410, createdName=慢热型选手, createdTime=Mon Aug 26 14:38:00 CST 2024, time=2024-08-26, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211332, encodeId=4a2e221133255, content=从大CDD转过来，从Under Consideration 9天直接变成了Decision Made，是不是完全没戏了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:36:13 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2218984, encodeId=d08822189842a, content=请问下，这个期刊的Manuscript Under Consideration 可能包含under review了吗？如何知道自己是否进入外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bfc22529575, createdName=124fb7cam10暂无昵称, createdTime=Wed Aug 07 19:58:51 CST 2024, time=2024-08-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1239796, encodeId=6c781239e966f, content=审稿速度:6.0 经验分享：under consideration80天了，谁说这个快来着。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08542281224, createdName=121c6f2dm84(暂无昵称), createdTime=Fri Aug 19 19:39:59 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141702, encodeId=2e522141e0276, content=偏重的研究方向：非编码RNA与肿瘤 经验分享：投大CDD被拒，建议转投小小CDD，考虑到邮件里说会尽快送外审，并且会尽快加快整个投稿流程，所以就投了。。。今天是第8天，一直都是编辑分配的阶段，好慢啊，感觉被骗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/z9epyLIJIgUahjrYamPc11XicFeIwsQ43sQAldibrhs7zKbRySIOxiajvItuia10Kicaywy53X5F4dDoav6k0MiadF1A/132, createdBy=a9182207296, createdName=影像哥哥, createdTime=Thu Jun 08 15:56:30 CST 2023, time=2023-06-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2200214, encodeId=241d2200214d6, content=求好运，编辑和审稿人一生平安！！！ Manuscript Under Consideration 11th Apr 24 05:59:46 Editor Assigned 10th Apr 24 04:50:35 Manuscript Received 10th Apr 24 04:50:34, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230127/dd490db5809c41dba47efd8445d736af/b6403d79e2fb4308b2f2b14ee7a06741.jpg, createdBy=1f234693702, createdName=白衣13, createdTime=Wed Apr 24 22:07:15 CST 2024, time=2024-04-24, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211331, encodeId=37242211331bd, content=从大CDD转过来的，Under Consideration9天就变成了Decision Made，是不是没戏直接悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72d52443072, createdName=123dc049m24(暂无昵称), createdTime=Mon Jun 24 10:34:44 CST 2024, time=2024-06-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2211626, encodeId=cafa221162697, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe2b2627122, createdName=36192448, createdTime=Tue Jun 25 20:10:32 CST 2024, time=2024-06-25, status=1, ipAttribution=湖南省)]

2024-06-25 36192448 来自湖南省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：给大家参考下：3.18号投稿，40天审完，一个月返修后5天，6.15号接收，6.25号见刊

62 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务